Hint mode is switched on Switch off

Amicus Therapeutics, ordinary share
FOLD, US03152W1099

Add a stock to WL
Choose all Reset all
Amicus Therapeutics, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Amicus Therapeutics, Inc., a biotechnology company, engages in the discovery, development, and commercialization of medicines for various rare and orphan diseases.
  • Issuer
  • Full borrower / issuer name
    Amicus Therapeutics, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    FOLD
  • Placement
    31.05.2007
  • Lock up period
    180
  • Number of papers
    5,000,000
  • Volume of raised funds
    75 mln USD
  • Final placement price
    15 USD
  • Price change since placement date
    -3.4%
  • By capitalization
    333.52 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    FOLD
  • Placement
    19.11.2014
  • Lock up period
    180
  • Number of papers
    13,850,000
  • Volume of raised funds
    90.03 mln USD
  • Placement share
    14.88%
  • Final placement price
    6.5 USD
  • Price change since placement date
    122.92%
  • By capitalization
    605.2 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    FOLD
  • Placement
    12.06.2015
  • Lock up period
    180
  • Number of papers
    16,981,132
  • Volume of raised funds
    225 mln USD
  • Placement share
    14.98%
  • Final placement price
    13.25 USD
  • Price change since placement date
    9.36%
  • By capitalization
    1,501.97 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2025
I q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide

Indicators

News

27/04/2026 Amicus Therapeutics: Termination Of A Material Definitive Agreement, Completion Of Acquisition Or Disposition Of Assets, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Material Modification To Rights Of Security Holders, Changes In Control Of Registrant, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Amendments To Articles Of Incorporation Or Bylaws; Change Of Fiscal Year, Financial Statements And Exhibits
23/04/2026 Amicus Therapeutics: Other Events
20/02/2026 Amicus Therapeutics: – Results Of Operations And Financial Condition, Financial Statements And Exhibits
26/01/2026 Amicus Therapeutics: Results Of Operations And Financial Condition, Regulation Fd
20/12/2025 Amicus Therapeutics Downgraded by Needham Amid BioMarin Acquisition
All organization news

Holders

Industry Leaders

Registration is required to get access.